CD208+ cells predominated over CD1a+ in OM and PT of both pCRC and LM in both cohorts (p < 0.05), whereas in synchronous disease CD1a+ cells exceeded CD208+ in pCRC IM (p < 0.01) and LM TC (p < 0.05). Here, CD1A is linked to ocular melanoma.